Poseida Therapeutics | 4:持股变动声明-董事 Lloyd Marcea Bland
Poseida Therapeutics | 4:持股变动声明-董事 Schmid John P.
Poseida Therapeutics | 4:持股变动声明-董事 Collins Cynthia
Poseida Therapeutics | 4:持股变动声明-董事 Corning Luke
Poseida Therapeutics | 4:持股变动声明-董事 BAUM CHARLES M
Poseida Therapeutics | 8-K:重大事件
Poseida Therapeutics | 4:持股变动声明-董事 Amado Rafael
Poseida Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(4.97%)
Poseida Therapeutics | 10-Q:季度报表
Poseida Therapeutics | 8-K:Poseida Therapeutics提供2024年第一季度的最新情况和财务业绩
Poseida Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Novartis Pharma AG(0%),Novartis AG(0%)
Poseida Therapeutics | EFFECT:其他
Poseida Therapeutics | CORRESP:信函
Poseida Therapeutics | 8-K:重大事件
Poseida Therapeutics | ARS:年度报告
Poseida Therapeutics | DEFA14A:其他
Poseida Therapeutics | DEF 14A:股东委托书决议
Poseida Therapeutics | 8-K:重大事件
Poseida Therapeutics | UPLOAD:其他
Poseida Therapeutics | S-3:特定交易注册声明
暂无数据